Safety and efficacy of Dolutegravir and EFV400 for pregnant and breastfeeding women: a randomized non-inferiority clinical trial

FOCUS

PREGART clinical trial in Ethiopia achieved 25% of the participant’s recruitment

The PREGART Clinical trial in Ethiopia has been enrolling participants since May 2021. The participant recruitment was initiated after 18 months of…

Ethiopia Food and Regulatory Authority (EFDA) conducted a GCP inspection on the PREGART clinical trial implementation

The Ethiopia Food and Regulatory Authority (EFDA) pharmacovigilance and clinical trial authorization unit conducted an inspection of the PREGART…

Good Clinical Practice (GCP), Good Clinical laboratory practice (GCLP) and Protocol familiarization training – Ethiopia

The PREGART Clinical trial project conducted its kick-off meeting in September 2019. However, the trial participant recruitment initiated after two…

Stakeholders engagement meeting at Adama, Ethiopia

The Pregart Clinical trial in Ethiopia has been enrolling participants since May 2021. The project has enrolled 16% of its target as of June 2022.…

Pregart clinical trial situation in Uganda

The recruitment of trial participants on the Ugandan arm of the Pregart study kicked off on the 28th of September 2021 and it has been running…

Update on Pregart clinical trial participant recruitment as of 13th October 2021

The Ugandan team started participant recruitment on 21st September 2021, with a total of 8 participants recruited to date. Prior to recruitment we…

PREGART video presentation

DOCUMENTS

Short facts

PREGART brief description

DOWNLOAD PDF

Impact

Impact of PREGART project

DOWNLOAD PDF

The project

Full description of PREGART project

DOWNLOAD PDF

Work packages

Work packages of PREGART project

DOWNLOAD PDF